US Market Report for Neurovascular Stents 2017 - MedCore
NEW YORK, Dec. 13, 2016 /PRNewswire/ --
Description
High single digit market growth will be seen throughout the forecast period for neurovascular stents as next generation devices continue to enter the U.S. market. Traditional coil assisted stenting will continue to grow in unit sales while flow diversion stenting, a new and promising endovascular treatment, will experience rapid growth as well. Sales of these devices in the U.S. only began in 2011 following the approval of the Pipeline™ device from Medtronic. Flow diversion stents have the potential to cannibalize a portion of traditional stent sales but they will both continue to experience growth. These increases in unit sales will also be driven by innovation in these devices making them smaller and able to place in more distal locations. The high market value is in part attributable to the fact that flow diversion stents command an ASP of nearly twice that of a traditional stent. Both types of stents are expected to experience marginal increases in pricing due to innovation, which will also drive market growth.
Abstract
There are two main types of neurovascular stents currently on the market, the traditional stent and the flow diverter stent. They are both used as treatments for cerebral aneurysms. Traditional neurovascular stents are small, flexible, tube-like devices used for stabilizing detachable coils within an aneurysm. They serve to block off the aneurysm and to prevent coils from slipping back into the main blood vessel. These stents are also used to treat intracranial stenosis by opening blocked arteries. These stents are delivered in reduced tube structures for easier navigation and delivery through the narrow intracranial vessels. As brain arteries are more fragile than carotid arteries, a self-expanding stent that gently opens to the desired vessel diameter is generally used. Self-expandable stents carry a lower risk of dissection or vessel rupture when compared to the balloon-expandable stents.
Scope:2013-2023
Companies
Medtronic
Boston Scientific
St. Jude Medical
Cyberonics
Codman & Shurtleff
Stryker
Integra LifeSciences
InoMed
Mizuho America
RauMedic
Read the full report: http://www.reportlinker.com/p04353033-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare:
[email protected]: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article